Nirsevimab Effective for Preventing RSV-Linked Hospitalization

FRIDAY, March 8, 2024-- Receipt of a single dose of nirsevimab is effective for preventing respiratory syncytial virus (RSV)-associated hospitalization for infants, according to research published in the March 7 issue of the U.S. Centers for...